Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GC-rich DNA binding sites, commonly known as GC boxes, are critical cis-regulatory elements found in the promoter regions of numerous housekeeping and tissue-specific genes (Suske, G., 1999, Gene). These sequences, typically characterized by the consensus motif 5'-GGGGCGGGG-3', serve as the primary docking sites for the Specificity Protein (Sp) and Kruppel-like factor (KLF) families of transcription factors (Safe, S., & Abdelrahim, M., 2005, Eur J Cancer). By facilitating the recruitment of the transcriptional machinery, these sites play a fundamental role in regulating essential cellular processes such as proliferation, differentiation, and apoptosis. In many cancers, the over-activation of genes regulated by these GC-rich sites contributes to tumor progression, angiogenesis, and resistance to therapy (Vizcaíno, C., et al., 2015, Gene). Consequently, these DNA sequences have emerged as therapeutic targets for minor groove-binding agents like Mithramycin A, which competitively inhibit transcription factor binding (Previdi, S., et al., 2010, PLoS One). Targeting these sites offers a strategy to downregulate multiple oncogenic pathways simultaneously, although clinical utility is often limited by systemic toxicity and a narrow therapeutic window (PubChem, CID 16218737).
Minor groove binding to GC-rich DNA sequences to sterically inhibit the binding of Sp1 and KLF transcription factors.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GC-rich DNA binding site (GC box) (GC box).